1. Home
  2. TECX vs CRESY Comparison

TECX vs CRESY Comparison

Compare TECX & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$32.34

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

HOLD

Current Price

$10.78

Market Cap

738.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
CRESY
Founded
2019
1936
Country
United States
Argentina
Employees
60
2889
Industry
Real Estate
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
738.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
CRESY
Price
$32.34
$10.78
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
150.1K
233.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
8.14%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.92
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$8.39
52 Week High
$39.53
$14.21

Technical Indicators

Market Signals
Indicator
TECX
CRESY
Relative Strength Index (RSI) 57.13 43.79
Support Level $27.30 $10.56
Resistance Level $35.99 $11.83
Average True Range (ATR) 1.50 0.39
MACD 0.16 -0.05
Stochastic Oscillator 97.14 13.71

Price Performance

Historical Comparison
TECX
CRESY

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

Share on Social Networks: